Edition:
United States

Bioanalytical Systems Inc (BASI.OQ)

BASI.OQ on NASDAQ Stock Exchange Capital Market

1.25USD
4:00pm EDT
Change (% chg)

$0.03 (+2.46%)
Prev Close
$1.22
Open
$1.24
Day's High
$1.28
Day's Low
$1.24
Volume
1,545
Avg. Vol
52,980
52-wk High
$2.42
52-wk Low
$0.60

Latest Key Developments (Source: Significant Developments)

BASI Q1 EPS $0.00
Tuesday, 14 Feb 2017 08:30am EST 

Bioanalytical Systems Inc : BASI reports first quarter results . Q1 earnings per share $0.00 . Q1 revenue rose 26 percent to $6.174 million . Bioanalytical Systems - board has directed management to seek alternatives to enable co to repay indebtedness to Huntington Bank in full . Bioanalytical Systems - continues to explore initiatives to address credit issues, including but not limited to, potential disposition of certain assets . Bioanalytical Systems Inc - company continues to explore initiatives such as possible sale and leaseback of building in West Lafayette, Indiana . Bioanalytical Systems Inc - management has been, and continues to be actively engaged in more effectively controlling operating costs .Bioanalytical Systems Inc - board of directors continues to weigh options for replacing chief executive officer.  Full Article

Bioanalytical Systems says co entered into fifth forbearance agreement and sixth amendment to credit agreement
Wednesday, 1 Feb 2017 01:44pm EST 

Bioanalytical Systems Inc : Bioanalytical Systems - effective Jan 31, co entered into a fifth forbearance agreement and sixth amendment to credit agreement - SEC filing .Bioanalytical Systems Inc - fifth forbearance agreement amends maturity dates for term and revolving loans under credit agreement to July 31, 2017.  Full Article

Bioanalytical Systems Q4 loss per share $0.25
Thursday, 22 Dec 2016 08:30am EST 

Bioanalytical Systems Inc : Bioanalytical Systems - management to seek alternatives to enable co to repay indebtedness to Huntington bank in full upon expiration of forbearance period . BASi reports fiscal 2016 full year and fourth quarter results . Q4 loss per share $0.25 .Q4 revenue rose 3.6 percent to $5.154 million.  Full Article

Bioanalytical Systems' CEO Jacqueline Lemke to resign
Tuesday, 8 Nov 2016 05:52pm EST 

Bioanalytical Systems Inc : Bioanalytical Systems - on Nov 2, Jacqueline Lemke informed board of her intent to resign from her positions of president and chief executive officer .Says co's board of directors is in process of identifying Lemke's successor.  Full Article

Bioanalytical Systems entered third forbearance agreement,fourth amendment to credit agreement-SEC filing
Monday, 3 Oct 2016 11:37am EDT 

Bioanalytical Systems Inc : Effective Sept 30, Co entered third forbearance agreement ,fourth amendment to credit agreement-SEC filing . Third forbearance agreement amends maturity dates for term and revolving loans under credit agreement to october 31, 2016 . Third forbearance agreement removes additional financial covenant contained in second forbearance agreement .In connection with third forbearance agreement, CO agreed to reimburse Huntington Bank for certain legal fees ,to pay a loan forbearance fee..  Full Article

Basi Q3 loss per share $0.05
Thursday, 11 Aug 2016 08:30am EDT 

Bioanalytical Systems Inc : Basi reports third quarter results .Q3 revenue fell 17.8 percent to $5.053 million.  Full Article

Bioanalytical Systems elects Larry Boulet as Board's chairman
Thursday, 4 Aug 2016 02:03pm EDT 

Bioanalytical Systems Inc :On July 28, company’s board of directors voted unanimously to elect Larry Boulet as chairman of the board - SEC Filing.  Full Article

Bioanalytical Systems says John B. Landis retired as Chairperson
Friday, 22 Jul 2016 03:14pm EDT 

Bioanalytical Systems Inc : Says John B. Landis retired as Chairperson of the board - SEC Filing Source - http://bit.ly/29U2Ks4 Further company coverage: [BASI.O] (Bengaluru Newsroom; +1 646 223 8780).  Full Article

Bioanalytical Systems posts Q2 loss per share of $0.03
Thursday, 12 May 2016 09:56am EDT 

Bioanalytical Systems Inc : BASI reports second quarter results . Says for three months ended March 31, 2016, revenue was $5.3 million, a 6.8 pct decrease . Exploring initiatives to address solutions to credit issues, which include evaluation, pursuit of various sources of financing .Q2 loss per share $0.03.  Full Article

Bioanalytical Systems appoints Jill C. Blumhoff as CFO
Wednesday, 11 May 2016 11:01am EDT 

Bioanalytical Systems Inc : Bioanalytical Systems Inc announces appointment of new chief financial officer . Says Jill C. Blumhoff appointed CFO .Blumhoff succeeds Jeffrey Potrzebowski effective with his retirement from company on May 9, 2016.  Full Article

More From Around the Web

BRIEF-BASI Q1 EPS $0.00

* Bioanalytical Systems - board has directed management to seek alternatives to enable co to repay indebtedness to Huntington Bank in full